These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36521659)

  • 21. Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study.
    Boarini LR; Sobrado CW; Mota GR; Villa LL; de Albuquerque IC; Queiroz NSF; Facanali CBG; Nadal SR; Cecconello I
    Clinics (Sao Paulo); 2023; 78():100219. PubMed ID: 37257365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW; Baumgart DC
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae.
    Frei SM; Hemsley C; Pesch T; Lang S; Weber A; Jehle E; Rühl A; Fried M; Rogler G; Scharl M
    PLoS One; 2013; 8(11):e78882. PubMed ID: 24250816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study.
    Palmieri C; Müller G; Kroesen AJ; Galata C; Rink AD; Morgenstern J; Kruis W
    J Crohns Colitis; 2021 Oct; 15(10):1686-1693. PubMed ID: 33772272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
    Garcia-Olmo D; Gilaberte I; Binek M; D Hoore AJL; Lindner D; Selvaggi F; Spinelli A; Panés J
    Dis Colon Rectum; 2022 May; 65(5):713-720. PubMed ID: 34890373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.
    Siegmund B; Feakins RM; Barmias G; Ludvig JC; Teixeira FV; Rogler G; Scharl M
    J Crohns Colitis; 2016 Apr; 10(4):377-86. PubMed ID: 26681764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TSG-6 is concentrated in the extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-alpha-inhibitor binding.
    Carrette O; Nemade RV; Day AJ; Brickner A; Larsen WJ
    Biol Reprod; 2001 Jul; 65(1):301-8. PubMed ID: 11420253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: pathogenesis of Crohn's perianal fistula-understanding factors impacting on success and failure of treatment strategies.
    Tozer PJ; Lung P; Lobo AJ; Sebastian S; Brown SR; Hart AL; Fearnhead N;
    Aliment Pharmacol Ther; 2018 Aug; 48(3):260-269. PubMed ID: 29920706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
    Kotze PG; Spinelli A; Warusavitarne J; Di Candido F; Sahnan K; Adegbola SO; Danese S
    Drugs Today (Barc); 2019 Feb; 55(2):95-105. PubMed ID: 30816884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in fistulizing perianal Crohn's disease: A multicentre randomized controlled trial.
    Abramowitz L; Brochard C; Pigot F; Roumeguere P; Pillant H; Vinson Bonnet B; Faucheron JL; Senéjoux A; Bonnaud G; Meurette G; Fayette JM; Train C; Staumont G; Siproudhis L; Bouchard D
    Colorectal Dis; 2022 Feb; 24(2):210-219. PubMed ID: 34623746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronan cable formation by ocular trabecular meshwork cells.
    Sun YY; Keller KE
    Exp Eye Res; 2015 Oct; 139():97-107. PubMed ID: 26247678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial.
    Maciel Gutiérrez VM; Gutiérrez Guillen SG; Centeno Flores MW; Valenzuela Pérez JA; Abarca Rendón FM; Hernández García FS; De la Cerda Trujillo LF; Gómez Torres GÁ
    Dis Colon Rectum; 2021 Mar; 64(3):328-334. PubMed ID: 33538521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
    Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
    Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    van Rijn KL; Meima-van Praag EM; Bossuyt PM; D'Haens GR; Gecse KB; Horsthuis K; Snijder HJ; Tielbeek JAW; Buskens CJ; Stoker J
    J Crohns Colitis; 2022 Jun; 16(5):708-716. PubMed ID: 34644395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
    Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
    Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.
    Singh A; Kakkar C; Garg S; Arora K; Midha V; Mahajan R; Virk SS; Jain NP; Singh D; Sood K; Tripathi A; Gupta D; Kaushal IG; Galhotra RD; Saggar K; Sood A
    Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 39. The Intersection of Human and Veterinary Medicine-A Possible Direction towards the Improvement of Cell Therapy Protocols in the Treatment of Perianal Fistulas.
    Burdzinska A; Galanty M; Więcek S; Dabrowski FA; Lotfy A; Sadkowski T
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.